Abstracts

2016

Neoantigen Summit 2016, Boston, USA

Targeting neoantigens by TCR therapy: Are we limited to treatment of tumors with highmutational loads and patients with pre-existing neoantigen-specific T cells? Dolores J. Schendel, CEO and CSO Medigene AG, Munich Germany

Download

ACCR - American Association for Cancer Research 2016, New Orleans, LA, USA

Tryggestad A., Axcrona K., Bigalke I., Inderberg-Suso, E., Skorstad, G., Axcrona U., Aamdal S., Gaudernack G., Schendel D., Lilleby W., Dueland S. and Kvalheim G. 2016. Clinical results of a Phase I/II trial of adjuvant therapeutic vaccination in high risk resected prostate cancer patients using autologous dendritic cells loaded with mRNA from primary prostate cancer tissue, hTERT and survivin. AACR, New Orleans, USA

Further information

2015

ASH - American Society of Hematology Annual Meeting 2015, Orlando FL, USA

Bigalke I., Fløisand Y., Solum G., Hønnåshagen K., Lundby M., Anderson K., Sæbøe-Larssen S., Inderberg E., Eckl J., Schendel D., and Kvalheim G. 2015. AML Patients in Minimal Residual Disease Vaccinated with a Novel Generation of Fast Dendritic Cells Expressing WT-1 and PRAME Mount Specific Immune Responses That Relate to Clinical Outcome. ASH Orlando, USA. 

Further information

Phacilitate Immunotherapy Forum 2015, Washington DC, USA

Schendel D. 2014. Tailoring immunotherapies for patients with different stages of prostate cancer. Phacilitate Conference Washington DC, USA.

Download PDF

2014

ASH - American Society of Hematology Annual Meeting 2014, San Francisco, USA

Bigalke I., Honnashagen K., Lundby M., Kasten J., Suso Inderberg E., Skoge L., Saboe-Larssen S., Schendel D., Kvalheim G. 2014. 2440 Vaccination with a New Generation of Fast Dendritic Cells Transfected with mRNA from hTERT, Survivin and Autologous Tumor Mount Strong Immune Responses and Prolong Survival. ASH San Francisco, USA.

Download PDF

SITC - Society for Immunotherapy of Cancer Annual Meeting 2014, National Harbor MD, USA

Schnorfeil F., Lichtenegger F., Geiger C., Köhnke T.,  Bücklein V., Altmann T., Wagner B., Henschler R., Bigalke I, Kvalheim G., Hiddemann W., Schendel D.J., Subklewe M. 2014. Next-generation dendritic cells for immunotherapy of acute myeloid leukemia. SITC National Harbor, USA.

Download PDF

SITC - Society for Immunotherapy of Cancer Annual Meeting 2014, National Harbor MD, USA

Wehner C., Ellinger C., Raffegerst S., Wilde S., Mosetter B., Weis M., Longinotti G., Sailer N., Schendel D.J., Milošević S. 2014. Generation of tumor antigen specific CD4+ and CD8+ T cells by simultaneous MHC-I and –II epitope presentation in vitro and in vivo. SITC National Harbor, USA.

Download PDF

PIVAC - Progress in Vaccination Against Cancer 2014, Rom

Tryggestad A., Axcrona K., Bigalke I.,MInderberg-Suso E., Skorstad G, Axcrona U.,Steinar A., Gaudernack G.,Lilleby W., Dueland S., Kvalheim G. 2014. A PhaseI/II trial of adjuvant therapeutic vaccination in resected prostate cancer patients using autologous dendritic cells loaded with mRNA from primary prostate cancer tissue,hTERT and survivin. PIVAC Rome, Italy.

Download PDF

PIVAC - Progress in Vaccination Against Cancer 2014, Rom

Rampp I., Eichenlaub S., Römer I., Pohla H., Bigalke I., Sæbøe-Larssen S., Krackhardt A., Schendel D.J. Geiger C. 2014. Evaluation of a new generation dendritic cell-based vaccine for treatment of patients with castration-resistant prostate cancer. PIVAC Rome, Italy.

Download PDF

1st Immunotherapy of Cancer Conference 2014, München

Lichtenegger F., Beck B., Geiger C., Bigalke I., Kvalheim G., Hiddemann W., Schendel D., Subklewe M. 2014. Dendritic cell vaccination for postremission therapy in AML. ITOC Munich, Germany.

Download PDF

CIMT - Cancer Immunotherapy Annual Meeting 2014, Mainz

Tryggestad A.M.A., Bigalke I., Skorstad G., Skoge L.J., Honnashagen T.K., Axcrona K., Lilleby W., Kvalheim G. 2014. Cancer vaccines with hTERT and Survivin mRNA transfected fast DCs – a simplified and effective cancer vaccine. CIMT  Mainz, Germany.

Download PDF

CIMT - Cancer Immunotherapy Annual Meeting 2014, Mainz 

Schnorfeil F.M., Lichtenegger F.S., Geiger C., Beck B., Koehnke T., Buecklein V., Altmann T., Wagner B., Henschler R., Bigalke I., Kvalheim G., Hiddemann W., Schendel D.J., Subklewe M. 2014. Next-generation dentritic cell vaccination as postremission therapy in AML. CIMT Mainz, Germany.

Download PDF

CIMT - Cancer Immunotherapy Annual Meeting 2014, Mainz

Rampp I.S., Eichenlaub S., Römer I., Pohla H., Bilgalke I., Saeboe-Larssen S., Schendel D.J., Geiger C. 2014. Development of a next generation  dentritic cell-based immunotherapie for patients with castration-resistant prostate cancer. CIMT Mainz, Germany.

Download PDF

CIMT - Cancer Immunotherapy Annual Meeting 2014, Mainz 

Lorenz F.K.M., Wilde S., Voigt K., Kieback E., Schendel D.J., Uckert W. 2014. Gene optimization can generate cryptic epitopes that induce T cell responses. CIMT Mainz, Germany.

Download PDF

CIMT - Cancer Immunotherapy Annual Meeting 2014, Mainz 

Bigalke I.,Honnashagen K., Lundby M., Kasten J., Inderberg Suso E.-M., Skoge L., Saboe-Larssen S., Schendel D.J., Kvalheim G. 2014. First clinical experience with a new generation of fast DCs transfected with mRNA from hTERT, survivin and autologous tumor. CIMT Mainz, Germany.

Download PDF

BioM seminar series 2014: m4-personalized medicine, München

Dr. Geiger C. 2014. A dendritic cell-based immunotherapy for patients with castration-resistant prostate cancer (CRPC). BioM Munich, Germany.

Download PDF

BioM forum 2014: Development and approval of ATMPs, München

Dr. Geiger C. 2014. "Dendritische Zellvakzine zur Behandlung minimaler residualer Krebserkrankungen - Discovery und Präklinik" (A dendritic cell vaccine for treatment of patients with minimal residual disease – discovery and pre-clinical development). BioM Munich, Germany.

Download PDF

Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V. Jahrestagung 2014, Hamburg 

Kobold S., Steffen J., Chaloupka M., Grassmann S., Henkel J., Castoldi R., Yi Zeng, Chmiliewski M., Schmollinger J., Schnurr M., Rothenfußer S., Schendel D.J., Abken H., Sustmann C, Niederfellner G., Klein C., Bourquin C., Endres S. 2014. Bispecific T cell recruiting antibody enhances anti-tumor activity of adoptive T cell transfer. DGHO Hamburg, Germany.

Download PDF

European Society for Blood and Marrow Transplantation Annual Meeting 2014, Mailand

von Luettichau I., Salat C., Wawer A.,  Noessner E.,  Eckl J.,  Multhoff G., Thiel U., Issels R.D., Kolb H.J., Burdach S. 2014. Targeting the Graft-Versus-Tumor Effect of DLI by Regional Hyperthermia to the Tumor Compartment. EBMT Milan, Italy.

Download PDF

2013

CIMT - Cancer Immunotherapy Annual Meeting 2013, Mainz

Ellinger C., Wehner C., Wilde S., Schendel D.J., Milošević S. Mai 2013. MHC Class-II Expression Targeting (CrossTAg) for the Generation of Tumor-Antigen-Specific CD4+ T Lymphocytes. CIMT Mainz, Germany.

Download PDF

CIMT - Cancer Immunotherapy Annual Meeting 2013, Mainz

Wehner C., Ellinger C., Raffegerst S., Wilde S., Mosetter B., Schendel D.J., Milošević S., 2013. Isolation of antigen-specific CD8+ T lymphocytes and molecular characterization of antigenic epitopes. CIMT Mainz, Germany.

Download PDF

SITC - Society for Immunotherapy of Cancer Annual Meeting 2013, National Harbor MD (USA)

Ellinger C., Wehner C., Wilde S., Schendel D.J., Milošević S. 2013. Induction and isolation of tumor antigen-specific CD4+ T lymphocytes using sorting signal directed MHC class-II expression. SITC National Harbor MD, USA.

Download PDF

SITC - Society for Immunotherapy of Cancer Annual Meeting 2013, National Harbor MD (USA)

Wehner C., Ellinger C., Raffegerst S., Wilde S., Mosetter B., Schendel D.J., Milošević S. 2013. Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo. SITC National Harbor MD, USA.

Download PDF

SITC - Society for Immunotherapy of Cancer Annual Meeting 2013, National Harbor MD (USA)

Geiger C., Beck B., Bigalke I., Lichtenegger F.S., Heemskerk M., Saboe-Larssen S., Kvalheim G., Schendel D.J., Subklewe M. 2013. A new generation of dendritic cells optimized for the use in active immunotherapy – preclinical evaluation without an animal model. SITC National Harbor MD, USA.

Download PDF

Helmholtz  Alliance 2013, Asselheim

Marin V., Longinotti G., Wieczorek A., Willde S., Mosetter B., Raffegerst S., Eckl J., Ellinger C., Frankenberger B., Leisegang M., Uckert W., Spranger S., Uharek L., Schendel D. 2013. Setting up of a GMP-compliant method for the production of human TCR-transduced T cells for the clinical testing. Helmholtz Alliance Asselheim, Germany.

Download PDF

Helmholtz  Alliance 2013, Asselheim 

Marin V., Longinotti G. 2013. Status of  GMP process develompment for TCR expression in lymphocytes. Helmholtz Alliance Asselheim, Germany.

Download PDF

Cellular Therapie International Symposium 2013, Erlangen  

Wilde S., Mosetter B., Wehner C., Ellinger C., Milosevic S., Frankenberger B., Schendel D. 2013. Isolation of NY-ESO-1-specific T cell receptors restricted by non-HLA-A*02:01 allotypes for TCR gene therapy. Cellular Therapie International Symposium Erlangen, Germany.

Download PDF

Cellular Therapie International Symposium 2013, Erlangen   

Geiger C., Beck B., Bigalke I., Lichtenegger F.S., Heemskerk M.,  Saboe-Larssen S., Kvalheim G., Schendel D.J., Subklewe M. 2013. A DC-based therapeutic vaccine for AML patients: preclinical evaluation of a new generation of DCs expressing the leukemia-associated antigens WT1 and PRAME. Cellular Therapie International Symposium Erlangen, Germany.

Download PDF

ASH - American Society of Hematology Annual Meeting 2013, New Orleans LA (USA)

Lichtenegger F.S., Beck B., Geiger C., Munker D., Schlueter M., Draenert R., Kvalheim G., Hiddemann W., Schendel D.J., Subklewe M. 2013. Improving Efficacy of Dendritic Cell Vaccination in AML: Optimization of the DC Generation Protocol and Maximization of T Cell Responses by Immune Checkpoint Blockade. ASH New Orleans LA, USA.

Download PDF

Keystone Symposia 2013, USA

Smith S., Sommermeyer D.,  Schmitt T.,  Schendel D.J., Bernhard H., Piepenbrink K., Baker B., Blankenstein T., Uckert W., Greenberg P., Kranz D. 2013. Engineering high-affinity human single-chain T cell receptors against cancer antigens. Keystone Symposia, USA.

Download PDF

Acute Leukemias XIV, International Symposium 2013, München 

PD Dr. Subklewe M. 2013. Dendritic Cell Vaccination for Postremission Therapy in AML. Acute Leukemias XIV München, Germany.

Download PDF

European Society for Blood and Marrow Transplantation Annual Meeting 2013, London (UK)

Wieczorek A., Marin V., Raffegerst S., Wilde S., Mosetter B ., Spranger S., Frankenberger B., Leisegang M., Uckert W., Uharek L., Schendel D.J. 2013. HMMR-redirected adoptive T cell therapy for treatment of refractory acute myeloid leukemia in context of mismatched stem cell transplantation. EBMT London, UK.

Download PDF

2012

SFB TR 36 Annual Meeting 2012 Berlin 

Wilde S., Sommermeyer D., Leisegang M., Frankenberger B., Mosetter B., Uckert W., Schendel D.J. 2012. Human antitumor CD8+ T cells producing Th1-polycytokines show superior antigen sensitivity and tumor recognition. SFB TR 36 Berlin, Germany.

Download PDF